• Explore /
  • Poster
  • / HIF-pathway genes prognostic for progression-free and overall survival in metastatic clear cell renal cell carcinoma (mccRCC).

HIF-pathway genes prognostic for progression-free and overall survival in metastatic clear cell renal cell carcinoma (mccRCC).

Abstract Poster

Authors

Patrick Tamukong

Patrick Tamukong

Cedars-Sinai Medical Center, Los Angeles, CA

Patrick Tamukong , Paige Kuhlmann , Sungyong You , Shengchen Su , Yanping Wang , Eric Jay Small , Brian I. Rini , Susan Halabi , Jessica Janes , Stephen J. Freedland , Hyung Lae Kim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 370)

DOI

10.1200/JCO.2022.40.6_suppl.370

Abstract #

370

Poster Bd #

H4

Abstract Disclosures

Similar Posters

First Author: Marta Batus

First Author: Stefan Kubicka

First Author: Sahil D Doshi

First Author: Camila Bragança Xavier